(Q46523937)

22 December 2017

title

Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans (English)

1 reference

22 December 2017

author

José María Ordovás

9

1 reference

22 December 2017

author name string

Soo Jeong Koh

1

1 reference

22 December 2017

Yangsoo Jang

2

1 reference

22 December 2017

Yae Jung Hyun

3

1 reference

22 December 2017

Ju Yeon Park

4

1 reference

22 December 2017

Young Duk Song

5

1 reference

22 December 2017

Kyung-Kyun Shin

6

1 reference

22 December 2017

Jey Sook Chae

7

1 reference

22 December 2017

Byung-Keuk Kim

8

1 reference

22 December 2017

Jong Ho Lee

10

1 reference

22 December 2017

publication date

20 June 2008

1 reference

22 December 2017

published in

Clinical Endocrinology

1 reference

22 December 2017

volume

70

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

238-244

1 reference

22 December 2017

Inflammatory markers and risk of developing type 2 diabetes in women

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Interleukin 6: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Interleukin-6 -174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Effects of the Interaction between Interleukin-6 -634C/G Polymorphism and Smoking on Serum C-Reactive Protein Concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes: Results From the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2008.03315.X

10.1111/J.1365-2265.2008.03315.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017